Circulating Levels of CILP2 Are Elevated in Coronary Heart Disease and Associated with Atherosclerosis

Figure 1

Circulating CILP2 levels in the study population. (a) Distribution of CILP2 concentrations in healthy individuals (). (b) Circulating CILP2 levels according to sex ( for male, for female). (c) Circulating CILP2 levels in normal and CHD subjects ( for controls, and for CHD). (d) Prevalence of increased CHD in different quartiles of CILP2: quartile 1 (), < 104.7 ng/L; quartile 2 (), 104.7-133.7 ng/L; quartile 3 (), 133.7-163.3 ng/L; quartile 4 (), > 163.3 ng/L. (e) Circulating CILP2 concentrations in CHD patients according to the number of stenotic coronary arteries (number 0, ; number 1, ; number 2, ; number 3, ). (f) Increased CILP2 levels in different quartiles of Gensini score: quartile 1 (), < 12; quartile 2 (), 12-20; quartile 3 (), 20-42; quartile 4 (), > 42. Data were , or vs. male, controls, quartile 1, or number 0.

(a)

(b)

(c)

(d)

(e)

(f)